JTCC at Hackensack UMC — Hackensack, New Jersey

JTCC at Hackensack UMC is a clinical research site located in Hackensack, New Jersey, United States 07601.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

JTCC at Hackensack UMC has participated in 1 clinical trials.

Therapeutic areas: Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer.

Sponsors: Calithera Biosciences, Inc.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for JTCC at Hackensack UMC?

JTCC at Hackensack UMC has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has JTCC at Hackensack UMC conducted?

JTCC at Hackensack UMC has 1 clinical trials on record. Their work covers Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer.

Is JTCC at Hackensack UMC accredited by Crixeo Health?

JTCC at Hackensack UMC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about JTCC at Hackensack UMC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.